000 01570 a2200433 4500
005 20250513101504.0
264 0 _c19961204
008 199612s 0 0 eng d
022 _a0147-8389
024 7 _a10.1111/j.1540-8159.1996.tb03307.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStark, G
245 0 0 _aHow to measure AV nodal refractoriness in the presence of verapamil, amiodarone, digoxin, and diltiazem.
_h[electronic resource]
260 _bPacing and clinical electrophysiology : PACE
_cFeb 1996
300 _a157-64 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAmiodarone
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aAnti-Arrhythmia Agents
_xpharmacology
650 0 4 _aAtrioventricular Node
_xdrug effects
650 0 4 _aCardiac Pacing, Artificial
650 0 4 _aDigoxin
_xpharmacology
650 0 4 _aDiltiazem
_xpharmacology
650 0 4 _aElectrocardiography
_xdrug effects
650 0 4 _aFemale
650 0 4 _aFourier Analysis
650 0 4 _aGuinea Pigs
650 0 4 _aHeart Rate
_xdrug effects
650 0 4 _aMale
650 0 4 _aSignal Processing, Computer-Assisted
650 0 4 _aVerapamil
_xpharmacology
700 1 _aKasper, K
700 1 _aSchulze-Bauer, C
700 1 _aStark, U
700 1 _aDecrinis, M
700 1 _aTritthart, H A
773 0 _tPacing and clinical electrophysiology : PACE
_gvol. 19
_gno. 2
_gp. 157-64
856 4 0 _uhttps://doi.org/10.1111/j.1540-8159.1996.tb03307.x
_zAvailable from publisher's website
999 _c8828886
_d8828886